281 related articles for article (PubMed ID: 32306849)
21. [Biologics and further new drugs for rheumatic diseases since 2000].
Krüger K
Orthopade; 2018 Nov; 47(11):906-911. PubMed ID: 30280235
[TBL] [Abstract][Full Text] [Related]
22. Switching biologics in the treatment of psoriatic arthritis in Japan.
Yamamoto T; Ohtsuki M; Sano S; Morita A; Igarashi A; Okuyama R; Kawada A;
J Dermatol; 2019 Mar; 46(3):e113-e114. PubMed ID: 30156313
[No Abstract] [Full Text] [Related]
23. The role of methotrexate in psoriatic arthritis: what is the evidence?
Ianculescu I; Weisman MH
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S94-7. PubMed ID: 26470718
[TBL] [Abstract][Full Text] [Related]
24. Depression/anxiety symptoms in axial spondyloarthritis and psoriatic arthritis patients in Serbia: a pilot study.
Milutinovic S; Veljkovic K; Zlatanovic M; Radunovic G; Damjanov N
Rheumatol Int; 2019 Sep; 39(9):1595-1605. PubMed ID: 31309294
[TBL] [Abstract][Full Text] [Related]
25. Management of Psoriatic Arthritis: Traditional Disease-Modifying Rheumatic Agents and Targeted Small Molecules.
Soriano ER
Rheum Dis Clin North Am; 2015 Nov; 41(4):711-22. PubMed ID: 26476228
[TBL] [Abstract][Full Text] [Related]
26. Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.
Flouri ID; Markatseli TE; Boki KA; Papadopoulos I; Skopouli FN; Voulgari PV; Settas L; Zisopoulos D; Iliopoulos A; Geborek P; Drosos AA; Boumpas DT; Sidiropoulos P
J Rheumatol; 2018 Jun; 45(6):785-794. PubMed ID: 29606666
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the management of psoriatic arthritis.
Mease PJ
Curr Opin Rheumatol; 2004 Jul; 16(4):366-70. PubMed ID: 15201598
[TBL] [Abstract][Full Text] [Related]
28. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
[TBL] [Abstract][Full Text] [Related]
29. Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.
Metyas S; Tomassian C; Messiah R; Gettas T; Chen C; Quismorio A
Curr Rheumatol Rev; 2019; 15(3):234-237. PubMed ID: 30499418
[TBL] [Abstract][Full Text] [Related]
30. [Indications and efficacy of biologics in inflammatory arthritis].
Combe B
Bull Acad Natl Med; 2012 Oct; 196(7):1279-92; discussion 1293. PubMed ID: 23815014
[TBL] [Abstract][Full Text] [Related]
31. The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.
Smith JA
Curr Rheumatol Rep; 2016 Jun; 18(6):33. PubMed ID: 27105640
[TBL] [Abstract][Full Text] [Related]
32. Transforming clinical trials in rheumatology: towards patient-centric precision medicine.
Pitzalis C; Choy EHS; Buch MH
Nat Rev Rheumatol; 2020 Oct; 16(10):590-599. PubMed ID: 32887976
[TBL] [Abstract][Full Text] [Related]
33. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
Elyoussfi S; Thomas BJ; Ciurtin C
Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
[TBL] [Abstract][Full Text] [Related]
34. Biologics and small molecules in the management of psoriatic arthritis: Reproduction related issues in female and male patients.
Fischer-Betz R; Østensen M
Expert Rev Clin Pharmacol; 2021 Aug; 14(8):979-989. PubMed ID: 33982647
[TBL] [Abstract][Full Text] [Related]
35. Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysis.
Reygaerts T; Mitrovic S; Fautrel B; Gossec L
Joint Bone Spine; 2018 Jul; 85(4):405-410. PubMed ID: 29452303
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of treatment response in psoriatic arthritis.
Jani M; Barton A; Ho P
Curr Rheumatol Rep; 2015 Jul; 17(7):44. PubMed ID: 25980667
[TBL] [Abstract][Full Text] [Related]
37. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
[TBL] [Abstract][Full Text] [Related]
38. Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.
González-Fernández MÁ; Villamañán E; Jiménez-Nácher I; Moreno F; Herrero A; Balsa A
Farm Hosp; 2019 Jan; 43(1):24-30. PubMed ID: 30624170
[TBL] [Abstract][Full Text] [Related]
39. Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
Mease PJ
Nat Rev Rheumatol; 2012 May; 8(5):251-2. PubMed ID: 22549279
[No Abstract] [Full Text] [Related]
40. [Rheumatic diseases in pregnancy].
Märker-Hermann E; Bauer H; Gromnica-Ihle E
Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
